| Morgon Michael Fernaays, | |
|
711 Troy Schenectady Rd Ste 103, Latham, NY 12110 | |
| (518) 783-3110 | |
| (518) 220-9506 |
| Full Name | Morgon Michael Fernaays |
|---|---|
| Gender | Male |
| Speciality | Physical Therapist |
| Location | 711 Troy Schenectady Rd Ste 103, Latham, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1083193577 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | P10379 (New York) | Secondary |
| 225100000X | Physical Therapist | 043159 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Morgon Michael Fernaays, 711 Troy Schenectady Rd Ste 203, Latham, NY 12110-2461 Ph: (518) 782-3700 | Morgon Michael Fernaays, 711 Troy Schenectady Rd Ste 103, Latham, NY 12110 Ph: (518) 783-3110 |
News Archive
In the past 10 years, researchers in genome stability have observed that many kinds of cancers are associated with areas where human chromosomes break. More recently, scientists have discovered that slow or altered replication causes chromosomal breaking. But why does DNA replication stall?
Human papillomavirus (HPV) was found to be the main risk factor associated with increased incidence of an unusual type of cervical cancer called cervical adenocarcinoma, according to a study in the March 1 issue of the Journal of the National Cancer Institute.
TAXIS Pharmaceuticals, a drug-discovery company focused on developing a new class of antibiotic agents to treat life-threatening, multidrug-resistant bacterial infections, today announced the presentation of data demonstrating the promise of its lead clinical candidate, TXA709, in combating antibiotic resistance.
A 50-state survey conducted by the Kaiser Family Foundation found that state spending on Medicaid will increase 29 percent this year.
Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, has published research in Nature Chemical Biology demonstrating the first-ever selective irreversible inhibition of a viral protease using a targeted covalent drug.
› Verified 2 days ago
Ms. Marianne Elizabeth Vrobel, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1182 Troy Schenectady Rd, Suite Ll02, Latham, NY 12110 Phone: 518-220-9705 Fax: 518-220-9651 | |
Dr. Sarah Catherine Clift, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 601 Loudon Rd, Latham, Ny 12110, Latham, NY 12110 Phone: 518-348-9613 | |
Mr. Richard J. Waite, PT, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 250 Old Loudon Rd, Latham, NY 12110 Phone: 518-489-2020 | |
Thomas Christopher Nicolla Jr., PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 711 Troy Schenectady Rd, Suite 214, Latham, NY 12110 Phone: 518-690-2882 Fax: 518-690-2884 | |
Trisha Mackenzie, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 711 Troy Schenectady Rd, Suite 214, Latham, NY 12110 Phone: 518-690-2882 Fax: 518-690-2884 | |
Ketaki Nagarkar, Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 11 Century Hill Dr Ste 104, Latham, NY 12110 Phone: 518-713-4106 | |
Melissa Anne Ailor, P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 711 Troy Schenectady Rd, Suite 214, Latham, NY 12110 Phone: 518-690-2882 Fax: 518-690-2884 |